PK/PD Analysis

Persica Strengthens PP353 Case in Vertebrogenic Back Pain

London, UK — September 4, 2026 Persica Pharmaceuticals Limited announced the publication of new antibiotic exposure-response analyses supporting the...

By cGxPwire Editor
September 7, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

PK/PD Analysis

Persica Strengthens PP353 Case in Vertebrogenic Back Pain